News
The race to keep pace with drug use changes
Yale’s emergency department physicians alerted the clinical chemistry laboratory in mid-2023 of the need to develop testing for xylazine, a nonopiate sedative, analgesic, and muscle relaxant authorized for veterinary use. It is reported as an adulterant in illicit drug mixtures and has been detected in an increasing number of overdose deaths.
Source: CAP Today